share_log

Morgan Stanley Downgrades Treace Medical Concepts to Equal-Weight, Lowers Price Target to $5.5

Morgan Stanley Downgrades Treace Medical Concepts to Equal-Weight, Lowers Price Target to $5.5

摩根士丹利将Treace Medical Concepts的评级下调至同等权重,将目标股价下调至5.5美元
Benzinga ·  05/08 11:47

Morgan Stanley analyst Drew Ranieri downgrades Treace Medical Concepts (NASDAQ:TMCI) from Overweight to Equal-Weight and lowers the price target from $15 to $5.5.

摩根士丹利分析师德鲁·拉涅利将Treace Medical Concepts(纳斯达克股票代码:TMCI)的评级从增持下调至同等,并将目标股价从15美元下调至5.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发